Redefining the role of thiazolidinediones in the management of type 2 diabetes
Anthony H BarnettUniversity of Birmingham and Heart of England National Health Service Foundation Trust (Teaching), Birmingham, UKAbstract: There is a need to evaluate oral glucose-lowering agents not only for their value in achieving glycemic control but also for their impact on cardiac risk factor...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-01-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | http://www.dovepress.com/redefining-the-role-of-thiazolidinediones-in-the-management-of-type-2--a2794 |